Literature DB >> 23539479

Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion.

Hidetaka Noma1, Katsunori Shimada, Tatsuya Mimura.   

Abstract

The influence of retinal ischemia on changes of visual acuity, macular sensitivity, macular thickness, and macular volume is unclear after pars plana vitrectomy (PPV) for macular edema with branch retinal vein occlusion (BRVO). Twenty-three patients (23 eyes) with BRVO and macular edema underwent PPV. Retinal ischemia was evaluated from capillary non-perfusion on fluorescein angiography, and patients were classified as ischemic or nonischemic. Microperimetry was performed with a Micro Perimeter 1. Macular thickness and volume were measured by optical coherence tomography. Mean macular thickness within the central 4°, 10°, and 20° fields decreased significantly from before to 3 and 6 months after PPV (all P < 0.001). Likewise, total macular volume within the central 4°, 10°, and 20° fields decreased significantly from before to 3 and 6 months after PPV (all P < 0.001). Best-corrected visual acuity (BCVA) improved significantly from before to 3 and 6 months after PPV (P < 0.001). Furthermore, mean macular sensitivity within the central 4°, 10°, and 20° fields increased significantly from before to 3 and 6 months after PPV (P = 0.002, P = 0.001, and P = 0.001, respectively). There were no significant differences in the trend profiles of macular thickness, macular volume, and BCVA between the ischemic and nonischemic groups. However, there was a significant difference in the trend profile of macular sensitivity within the central 4°, 10°, and 20° fields between the ischemic and nonischemic groups (P = 0.017, P = 0.010 and P = 0.025, respectively). These findings suggest PPV may be more effective for improving macular sensitivity in ischemic than nonischemic BRVO.

Entities:  

Mesh:

Year:  2013        PMID: 23539479     DOI: 10.1007/s10792-013-9762-2

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  26 in total

1.  Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Katsunori Shimada
Journal:  Retina       Date:  2012-10       Impact factor: 4.256

2.  Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.

Authors:  Noritatsu Yamaike; Akitaka Tsujikawa; Atsushi Sakamoto; Masafumi Ota; Yuriko Kotera; Kazuaki Miyamoto; Mihori Kita; Nagahisa Yoshimura
Journal:  Retina       Date:  2009-06       Impact factor: 4.256

Review 3.  Ocular oxygenation and the treatment of diabetic retinopathy.

Authors:  Einar Stefánsson
Journal:  Surv Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 6.048

4.  Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Seiyo Harino; Katsunori Shimada
Journal:  Retina       Date:  2011-11       Impact factor: 4.256

5.  Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.

Authors:  H Noma; H Funatsu; M Yamasaki; H Tsukamoto; T Mimura; T Sone; T Hirayama; H Tamura; H Yamashita; A Minamoto; H K Mishima
Journal:  Eye (Lond)       Date:  2006-07-07       Impact factor: 3.775

6.  Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.

Authors:  David M Brown; Peter A Campochiaro; Robert B Bhisitkul; Allen C Ho; Sarah Gray; Namrata Saroj; Anthony P Adamis; Roman G Rubio; Wendy Yee Murahashi
Journal:  Ophthalmology       Date:  2011-08       Impact factor: 12.079

7.  Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion.

Authors:  Yoko Okunuki; Yoshihiko Usui; Naomichi Katai; Takeshi Kezuka; Masaru Takeuchi; Hiroshi Goto; Yoshihiro Wakabayashi
Journal:  Am J Ophthalmol       Date:  2011-01-22       Impact factor: 5.258

8.  Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.

Authors:  K Kriechbaum; S Michels; F Prager; M Georgopoulos; M Funk; W Geitzenauer; U Schmidt-Erfurth
Journal:  Br J Ophthalmol       Date:  2008-01-22       Impact factor: 4.638

9.  Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-01

10.  Hypertension and hyperlipidemia management in patients treated at community health centers.

Authors:  Anne C Kirchhoff; Melinda L Drum; James X Zhang; Jennifer Schlichting; Jessica Levie; James F Harrison; Susan A Lippold; Cynthia T Schaefer; Marshall H Chin
Journal:  J Clin Outcomes Manag       Date:  2008
View more
  1 in total

1.  Reduced light sensitivity due to impaired retinal perfusion in branch retinal vein occlusion.

Authors:  Hiroyuki Iijima
Journal:  Jpn J Ophthalmol       Date:  2017-11-01       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.